1-9 of 9
Marjorie Boissinot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Surface Expression of Mpl: Aberrant Mpl Trafficking In Myeloproliferative Neoplasms Is Linked to Insufficient Expression of Wild Type Jak2

Cédric Cleyrat, PhD, Mathias Vilaine, Marjorie Boissinot, PhD, Francois Girodon, MD, PhD, Mara P. Steinkamp, PhD, Irène Dobo, MD, Éric Lippert, MD, PhD, Isabelle Corre, PhD, Bridget S. Wilson, PhD, Sylvie Hermouet, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2820.
https://doi.org/10.1182/blood.V118.21.2820.2820
Published: 2011
Journal Articles

Up-Regulation of Anti-Inflammatory, STAT3-Activating Hepatocyte Growth Factor and Interleukin-11 In Polycythemia Vera Is Independent of JAK2 V617F and Contributes to the Growth of Clonal Erythroblasts

Marjorie Boissinot, Cedric Cleyrat, Mathias Vilaine, Yannick Jacques, Isabelle Corre, Sylvie Hermouet, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 796.
https://doi.org/10.1182/blood.V116.21.796.796
Published: 2010
Journal Articles

Polycythemia Vera with Multiple Clones Carrying Different Mutations (L611V, V617F, L611V/V617F) in Exon 14 of JAK2 .

Cédric Cleyrat, Jaroslav Jelinek, François Girodon, Marjorie Boissinot, Thierry Ponge, Jean-Luc Harousseau, Jean-Pierre Issa, Sylvie Hermouet, Sylvie Hermouet
Journal: Blood
Blood (2009) 114 (22): 3908.
https://doi.org/10.1182/blood.V114.22.3908.3908
Published: 2009
Journal Articles

Leukemic blasts in transformed JAK2-V617F –positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

Brief Report
Alexandre Theocharides, Marjorie Boissinot, François Girodon, Richard Garand, Soon-Siong Teo, Eric Lippert, Pascaline Talmant, Andre Tichelli, Sylvie Hermouet, Radek C. Skoda
Journal: Blood
Blood (2007) 110 (1): 375–379.
https://doi.org/10.1182/blood-2006-12-062125
Published: 2007
Includes: Supplemental data
Journal Articles

Myeloid Blasts in Transformed JAK2-V617F Positive Myeloproliferative Disorders Are Frequently Negative for the JAK2-V617F Mutation.

Alexandre Theocharides, Marjorie Boissinot, Richard Garand, François Girodon, Soon-Siong Teo, Eric Lippert, Andre Tichelli, Sylvie Hermouet, Radek C. Skoda
Journal: Blood
Blood (2006) 108 (11): 375.
https://doi.org/10.1182/blood.V108.11.375.375
Published: 2006
Journal Articles

Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis

Marjorie Boissinot, Eric Lippert, Francois Girodon, Irene Dobo, Marc Fouassier, Claude Masliah, Vincent Praloran, Sylvie Hermouet
Journal: Blood
Blood (2006) 108 (9): 3223–3224.
https://doi.org/10.1182/blood-2006-05-021527
Published: 2006
Journal Articles

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

Clinical Trials & Observations Brief Report
Eric Lippert, Marjorie Boissinot, Robert Kralovics, François Girodon, Irène Dobo, Vincent Praloran, Nathalie Boiret-Dupré, Radek C. Skoda, Sylvie Hermouet
Journal: Blood
Blood (2006) 108 (6): 1865–1867.
https://doi.org/10.1182/blood-2006-01-013540
Published: 2006
Journal Articles

The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)

Marjorie Boissinot, Richard Garand, Mohamed Hamidou, Sylvie Hermouet
Journal: Blood
Blood (2006) 108 (5): 1781–1782.
https://doi.org/10.1182/blood-2006-03-008227
Published: 2006
Journal Articles

Quantitative Analysis of Wild Type and V617F JAK-2 Expression in Neutrophils of Polycythemia Vera and Essential Thrombocythemia Patients at Diagnosis.

Eric Lippert, MD, Francois Girodon, MD, Robert Kralovics, PhD, Marjorie Boissinot, Irene Dobo, Vincent Praloran, MD, Nathalie Boiret, MD, Radek C. Skoda, MD, Sylvie Hermouet, MD
Journal: Blood
Blood (2005) 106 (11): 257.
https://doi.org/10.1182/blood.V106.11.257.257
Published: 2005